Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Gregg

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
JCO Clinical Cancer Informatics|March 16, 2018
Automating the Determination of Prostate Cancer Risk Strata From Electronic Medical RecordsJustin R Gregg, Maximilian Lang, Lucy L Wang, et al.
BJUI Compass|April 27, 2022
Increased body mass index is associated with operative difficulty during robot-assisted radical prostatectomyDaniel D Shapiro, John W Davis, Wendell H Williams, et al.
British Journal of Cancer|January 26, 2019
Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillanceJustin R Gregg, Jiali Zheng, David S Lopez, et al.
BJU International|September 23, 2024
Whole-body MRI for staging prostate cancer: a narrative reviewAndrew M Fang, Justin R Gregg, Curtis Pettaway, et al.
The Journal of Urology|September 5, 2018
Coffee, Caffeine Metabolism Genotype and Disease Progression in Patients with Localized Prostate Cancer Managed with Active SurveillanceJustin R Gregg, David S Lopez, Chad Reichard, et al.
BJU International|December 19, 2020
Temporal learning curve of a multidisciplinary team for magnetic resonance imaging/transrectal ultrasonography fusion prostate biopsyAhmet Urkmez, John F Ward, Haesun Choi, et al.
Oncoimmunology|December 15, 2018
Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohortQinchuan Wang, Justin R Gregg, Jian Gu, et al.
European Urology Focus|May 12, 2019
Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial DesignChad A Reichard, Janet Kukreja, Justin R Gregg, et al.
The Journal of Urology|July 29, 2020
The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active SurveillanceJustin R Gregg, Devaki Shilpa Surasi, Alexandria Childs, et al.
Future Oncology (London, England)|April 1, 2025
Darolutamide plus androgen-deprivation therapy: propensity score matching of ARASEC and historic clinical trial patientsRana R McKay, Ashley E Ross, Mark A Preston, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
JCO Clinical Cancer Informatics|March 16, 2018
Automating the Determination of Prostate Cancer Risk Strata From Electronic Medical RecordsJustin R Gregg, Maximilian Lang, Lucy L Wang, et al.
BJUI Compass|April 27, 2022
Increased body mass index is associated with operative difficulty during robot-assisted radical prostatectomyDaniel D Shapiro, John W Davis, Wendell H Williams, et al.
British Journal of Cancer|January 26, 2019
Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillanceJustin R Gregg, Jiali Zheng, David S Lopez, et al.
BJU International|September 23, 2024
Whole-body MRI for staging prostate cancer: a narrative reviewAndrew M Fang, Justin R Gregg, Curtis Pettaway, et al.
The Journal of Urology|September 5, 2018
Coffee, Caffeine Metabolism Genotype and Disease Progression in Patients with Localized Prostate Cancer Managed with Active SurveillanceJustin R Gregg, David S Lopez, Chad Reichard, et al.
BJU International|December 19, 2020
Temporal learning curve of a multidisciplinary team for magnetic resonance imaging/transrectal ultrasonography fusion prostate biopsyAhmet Urkmez, John F Ward, Haesun Choi, et al.
Oncoimmunology|December 15, 2018
Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohortQinchuan Wang, Justin R Gregg, Jian Gu, et al.
European Urology Focus|May 12, 2019
Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial DesignChad A Reichard, Janet Kukreja, Justin R Gregg, et al.
The Journal of Urology|July 29, 2020
The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active SurveillanceJustin R Gregg, Devaki Shilpa Surasi, Alexandria Childs, et al.
Future Oncology (London, England)|April 1, 2025
Darolutamide plus androgen-deprivation therapy: propensity score matching of ARASEC and historic clinical trial patientsRana R McKay, Ashley E Ross, Mark A Preston, et al.
Pageof 6